SW – Smurfit WestRock plc

SW — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.43

Margin Of Safety %

Put/Call OI Ratio

0.11

EPS Next Q Diff

0.44

EPS Last/This Y

0.87

EPS This/Next Y

0.97

Price

47.05

Target Price

54.1

Analyst Recom

1.11

Performance Q

16.17

Upside

-46.4%

Beta

0.9

Ticker: SW

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-06-02	SW	42.26	0.12	0.01	36930
2026-06-03	SW	42.15	0.12	0.33	37898
2026-06-04	SW	42.29	0.12	0.03	38033
2026-06-05	SW	41.28	0.12	0.71	38216
2026-06-08	SW	40.52	0.12	0.57	38409
2026-06-09	SW	41.38	0.12	1.06	38610
2026-06-10	SW	38.96	0.13	1.42	38697
2026-06-11	SW	42.72	0.13	0.00	38876
2026-06-12	SW	43.32	0.11	0.00	45279
2026-06-15	SW	44.53	0.11	0.14	47089
2026-06-16	SW	44.07	0.12	6.05	47450
2026-06-17	SW	43.42	0.13	0.10	44867
2026-06-18	SW	44.19	0.13	0.14	44779
2026-06-22	SW	45.4	0.12	0.03	28696
2026-06-23	SW	44.37	0.11	0.02	32005
2026-06-24	SW	46.56	0.09	0.01	38436
2026-06-25	SW	46.82	0.09	0.02	37978
2026-06-26	SW	47	0.11	0.02	33546
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-06-01	SW	41.24	-7.8	1190.1	2.22
2026-06-02	SW	42.31	-7.8	1229.4	2.22
2026-06-03	SW	42.14	-7.8	1180.3	2.22
2026-06-04	SW	42.30	-7.8	1190.5	2.22
2026-06-05	SW	41.28	-7.8	1140.4	2.22
2026-06-08	SW	40.52	-7.8	1151.2	2.22
2026-06-09	SW	41.38	-7.8	1198.0	2.22
2026-06-10	SW	38.95	-7.8	1071.2	2.22
2026-06-11	SW	42.73	-7.8	1322.7	2.22
2026-06-12	SW	43.31	-7.8	1197.1	2.22
2026-06-15	SW	44.53	-7.8	1231.3	2.22
2026-06-16	SW	44.06	-7.8	1175.3	2.22
2026-06-17	SW	43.40	-7.8	1165.5	2.22
2026-06-18	SW	44.19	-7.8	1224.8	2.22
2026-06-22	SW	45.42	-11.2	1218.3	2.22
2026-06-23	SW	44.36	-11.2	1126.0	2.22
2026-06-24	SW	46.56	-11.2	1241.1	2.22
2026-06-25	SW	46.83	-11.2	1167.6	2.22
2026-06-26	SW	47.05	-11.2	1153.8	2.21
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-06-02	SW	-2.19	1.42	5.17
2026-06-03	SW	-2.19	1.42	5.17
2026-06-04	SW	-2.19	1.42	5.17
2026-06-05	SW	-2.19	1.42	5.17
2026-06-08	SW	-2.19	1.37	5.17
2026-06-09	SW	-2.19	1.37	5.17
2026-06-10	SW	-2.19	1.37	5.26
2026-06-11	SW	-2.19	1.37	5.26
2026-06-12	SW	-2.19	1.37	5.26
2026-06-15	SW	-2.19	1.38	5.26
2026-06-16	SW	-2.19	1.38	5.26
2026-06-17	SW	-2.19	1.38	5.25
2026-06-18	SW	-2.40	1.38	5.25
2026-06-22	SW	-2.39	1.40	5.25
2026-06-23	SW	-2.26	1.40	5.26
2026-06-24	SW	-2.23	1.40	5.26
2026-06-25	SW	-2.23	1.40	5.25
2026-06-26	SW	-2.40	1.40	5.43
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

0.33

Avg. EPS Est. Current Quarter

0.45

Avg. EPS Est. Next Quarter

0.77

Insider Transactions

-2.4

Institutional Transactions

1.4

Beta

0.9

Average Sales Estimate Current Quarter

7913

Average Sales Estimate Next Quarter

8272

Fair Value

52.3

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

21.7

Max Drawdown 5-Year %

-54.4

Target Price

54.1

P/E

65.47

Forward P/E

14.73

PEG

0.68

P/S

0.79

P/B

1.36

P/Free Cash Flow

23.18

EPS

0.72

Average EPS Est. Cur. Y

2.21

EPS Next Y. (Est.)

3.18

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

1.22

Relative Volume

1.42

Return on Equity vs Sector %

-16.3

Return on Equity vs Industry %

-0.4

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

1153.8

◆ SW Consumer Cyclical

$46.98

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

10/20

Pullback

8/25

Volume

3/15

Valuation

13/20

TP/AR

2/10

Options

6/10

RSI

66.2

Range 1M

89.3%

Sup Dist

1.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

9/25

Growth

14/30

Estimates

4/20

Inst/Vol

8/15

Options

9/10

EPS Yr

13.8%

EPS NY

36.8%

52W%

70.8%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +74.9% upside

Quality

3/30

Valuation

18/30

Growth

11/25

Stability

5/10

LT Trend

4/5

Upside

+74.9%

Quality

MoS

11%

SW — P/E HistoricalPackaging & Containers

Smurfit WestRock plc

Sector: Consumer Cyclical

Industry: Packaging & Containers

Employees: 97000

Smurfit Westrock Plc, together with its subsidiaries, manufactures, distributes, and sells containerboard, corrugated containers, and other paper-based packaging products in North America, South America, Europe, Asia, Africa, Australia, and internationally. The company produces containerboard and paperboard; packaging of corrugated containers; consumer packaging; and offers solid board, kraft paper, and graphic board, as well as other packaging products, such as solidboard packaging, paper sacks and bag-in-box. It produces linerboard and corrugated medium and paperboard; and other paper-based packaging, such as folding cartons, inserts, labels and displays. The company primarily serves food and beverage, healthcare, beauty and personal care, garden, consumer goods, industrial, and foodservice markets. It markets its products through its own sales force, independent sales representatives, and independent distributors. Smurfit Westrock Plc was founded in 1934 and is headquartered in Dublin, Ireland.

Latest News

—

Caricamento notizie per SW…

stock quote shares SW – Smurfit WestRock plc Stock Price stock today

news today SW – Smurfit WestRock plc stock forecast ,stock prediction 2023 2024 2025

marketwatch SW – Smurfit WestRock plc yahoo finance google finance

stock history SW – Smurfit WestRock plc invest stock market

stock prices SW premarket after hours

ticker SW fair value insiders trading

MURA – Mural Oncology plc

MURA — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

2.66

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

2.04

Target Price

Analyst Recom

Performance Q

-1.45

Upside

N/A

Beta

2.88

Ticker: MURA

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-06-02	MURA	2.04	N/A	N/A	0
2026-06-03	MURA	2.04	N/A	N/A	0
2026-06-04	MURA	2.04	N/A	N/A	0
2026-06-05	MURA	2.04	N/A	N/A	0
2026-06-08	MURA	2.04	N/A	N/A	0
2026-06-09	MURA	2.04	N/A	N/A	0
2026-06-10	MURA	2.04	N/A	N/A	0
2026-06-11	MURA	2.04	N/A	N/A	0
2026-06-12	MURA	2.04	N/A	N/A	0
2026-06-15	MURA	2.04	N/A	N/A	0
2026-06-16	MURA	2.04	N/A	N/A	0
2026-06-17	MURA	2.04	N/A	N/A	0
2026-06-18	MURA	2.04	N/A	N/A	0
2026-06-22	MURA	2.04	N/A	N/A	0
2026-06-23	MURA	2.04	N/A	N/A	0
2026-06-24	MURA	2.04	N/A	N/A	0
2026-06-25	MURA	2.04	N/A	N/A	0
2026-06-26	MURA	2.04	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

Last Quarter Act. EPS

-0.21

Avg. EPS Est. Current Quarter

-0.37

Avg. EPS Est. Next Quarter

Insider Transactions

-2.62

Institutional Transactions

-16.45

Beta

2.88

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

0.64

P/Free Cash Flow

EPS

-6.93

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

-0.39

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

-242.8

Return on Equity vs Industry %

-227.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

No data found for MURA

MURA — P/E HistoricalDrug Manufacturers - Specialty & Generic

MURA

Latest News

—

Caricamento notizie per MURA…

stock quote shares MURA – Mural Oncology plc Stock Price stock today

news today MURA – Mural Oncology plc stock forecast ,stock prediction 2023 2024 2025

marketwatch MURA – Mural Oncology plc yahoo finance google finance

stock history MURA – Mural Oncology plc invest stock market

stock prices MURA premarket after hours

ticker MURA fair value insiders trading

MDT – Medtronic Plc

MDT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

1.44

Margin Of Safety %

Put/Call OI Ratio

0.56

EPS Next Q Diff

-0.2

EPS Last/This Y

2.2

EPS This/Next Y

0.46

Price

80.99

Target Price

96.48

Analyst Recom

1.79

Performance Q

-7.63

Upside

1.3%

Beta

0.56

Ticker: MDT

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-06-02	MDT	73.71	0.55	0.94	190778
2026-06-03	MDT	78.02	0.58	0.31	211013
2026-06-04	MDT	81.92	0.53	0.27	225518
2026-06-05	MDT	81.68	0.54	0.21	230063
2026-06-08	MDT	80.68	0.48	0.50	210901
2026-06-09	MDT	81.96	0.49	0.69	214709
2026-06-10	MDT	80.24	0.50	0.76	216519
2026-06-11	MDT	80.32	0.51	0.40	218654
2026-06-12	MDT	80.17	0.52	0.94	223558
2026-06-15	MDT	80.41	0.53	0.71	214826
2026-06-16	MDT	81.32	0.53	0.41	217628
2026-06-17	MDT	78.16	0.52	0.57	219423
2026-06-18	MDT	79.36	0.51	0.33	219736
2026-06-22	MDT	79.27	0.53	0.35	169903
2026-06-23	MDT	80.62	0.53	0.34	176145
2026-06-24	MDT	80.16	0.52	0.36	180442
2026-06-25	MDT	80.47	0.52	0.07	184807
2026-06-26	MDT	80.97	0.56	4.53	182318
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-06-01	MDT	73.97	-4.5	500.5	5.53
2026-06-02	MDT	73.47	-4.5	449.7	5.53
2026-06-03	MDT	78.06	-4.5	815.2	5.53
2026-06-04	MDT	81.92	-4.5	764.5	5.53
2026-06-05	MDT	81.65	10.4	468.8	6.06
2026-06-08	MDT	80.68	10.4	157.3	6.06
2026-06-09	MDT	81.95	10.1	309.2	5.95
2026-06-10	MDT	80.25	10.1	108.4	5.95
2026-06-11	MDT	80.34	10.1	230.1	5.95
2026-06-12	MDT	80.16	10.1	212.4	5.95
2026-06-15	MDT	80.41	10.1	238.3	5.95
2026-06-16	MDT	81.32	10.1	287.5	5.95
2026-06-17	MDT	78.13	10.1	9.5	5.95
2026-06-18	MDT	79.38	10.1	309.8	5.95
2026-06-22	MDT	79.26	10.1	-423.1	5.95
2026-06-23	MDT	80.63	10.1	-256.9	5.95
2026-06-24	MDT	80.14	10.1	-384.8	5.95
2026-06-25	MDT	80.49	10.1	-326.6	5.95
2026-06-26	MDT	80.99	10.1	-368.4	5.95
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-06-02	MDT	-4.35	0.67	1.14
2026-06-03	MDT	-3.93	0.67	1.14
2026-06-04	MDT	-3.93	0.67	1.14
2026-06-05	MDT	-3.93	0.67	1.14
2026-06-08	MDT	-3.93	0.50	1.14
2026-06-09	MDT	-3.93	0.50	1.14
2026-06-10	MDT	-4.23	0.50	1.31
2026-06-11	MDT	-4.23	0.50	1.31
2026-06-12	MDT	-4.23	0.50	1.31
2026-06-15	MDT	-4.23	0.51	1.31
2026-06-16	MDT	-4.23	0.51	1.31
2026-06-17	MDT	-4.23	0.51	1.31
2026-06-18	MDT	-4.23	0.51	1.31
2026-06-22	MDT	-4.23	0.51	1.31
2026-06-23	MDT	-3.29	0.51	1.31
2026-06-24	MDT	-2.54	0.51	1.31
2026-06-25	MDT	-2.54	0.51	1.31
2026-06-26	MDT	-2.54	0.51	1.44
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

1.55

Avg. EPS Est. Current Quarter

1.39

Avg. EPS Est. Next Quarter

1.35

Insider Transactions

-2.54

Institutional Transactions

0.51

Beta

0.56

Average Sales Estimate Current Quarter

9553

Average Sales Estimate Next Quarter

9495

Fair Value

95.51

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

40.4

Max Drawdown 5-Year %

-45.1

Target Price

96.48

P/E

21.73

Forward P/E

12.67

PEG

1.62

P/S

2.85

P/B

2.1

P/Free Cash Flow

19.1

EPS

3.73

Average EPS Est. Cur. Y

5.95

EPS Next Y. (Est.)

6.41

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

13.2

Relative Volume

1.14

Return on Equity vs Sector %

-17.7

Return on Equity vs Industry %

-2.1

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.11

EBIT Estimation

-368.4

◆ MDT Healthcare

$80.98

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

14/20

Pullback

10/25

Volume

1/15

Valuation

16/20

TP/AR

1/10

Options

4/10

RSI

Range 1M

79.1%

Sup Dist

1.7%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

13/30

Estimates

6/20

Inst/Vol

5/15

Options

6/10

EPS Yr

7.7%

EPS NY

7.3%

52W%

22.8%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟢 BUY +46.2% upside

Quality

10/30

Valuation

19/30

Growth

9/25

Stability

7/10

LT Trend

2/5

Upside

+46.2%

Quality

MoS

18%

MDT — P/E HistoricalMedical Devices

Medtronic plc.

Sector: Healthcare

Industry: Medical Devices

Employees: 95000

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

MDT

Latest News

—

Caricamento notizie per MDT…

stock quote shares MDT – Medtronic Plc Stock Price stock today

news today MDT – Medtronic Plc stock forecast ,stock prediction 2023 2024 2025

marketwatch MDT – Medtronic Plc yahoo finance google finance

stock history MDT – Medtronic Plc invest stock market

stock prices MDT premarket after hours

ticker MDT fair value insiders trading

ITRM – Iterum Therapeutics Plc

ITRM — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.85

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

0.1

EPS Last/This Y

EPS This/Next Y

0.35

Price

0.03

Target Price

Analyst Recom

Performance Q

-91.64

Upside

N/A

Beta

3.42

Ticker: ITRM

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-06-02	ITRM	0.03	N/A	N/A	0
2026-06-03	ITRM	0.03	N/A	N/A	0
2026-06-04	ITRM	0.03	N/A	N/A	0
2026-06-05	ITRM	0.03	N/A	N/A	0
2026-06-08	ITRM	0.03	N/A	N/A	0
2026-06-09	ITRM	0.03	N/A	N/A	0
2026-06-10	ITRM	0.03	N/A	N/A	0
2026-06-11	ITRM	0.03	N/A	N/A	0
2026-06-12	ITRM	0.03	N/A	N/A	0
2026-06-15	ITRM	0.03	N/A	N/A	0
2026-06-16	ITRM	0.03	N/A	N/A	0
2026-06-17	ITRM	0.03	N/A	N/A	0
2026-06-18	ITRM	0.03	N/A	N/A	0
2026-06-22	ITRM	0.03	N/A	N/A	0
2026-06-23	ITRM	0.03	N/A	N/A	0
2026-06-24	ITRM	0.03	N/A	N/A	0
2026-06-25	ITRM	0.03	N/A	N/A	0
2026-06-26	ITRM	0.03	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

Last Quarter Act. EPS

-0.2

Avg. EPS Est. Current Quarter

-0.14

Avg. EPS Est. Next Quarter

-0.1

Insider Transactions

1.46

Institutional Transactions

Beta

3.42

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

99.9

Max Drawdown 5-Year %

-99.9

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

-0.72

Average EPS Est. Cur. Y

-0.66

EPS Next Y. (Est.)

-0.31

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

337.7

Return on Equity vs Industry %

354.2

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.33

EBIT Estimation

9.2

No data found for ITRM

ITRM — P/E HistoricalBiotechnology

ITRM

Latest News

—

Caricamento notizie per ITRM…

stock quote shares ITRM – Iterum Therapeutics Plc Stock Price stock today

news today ITRM – Iterum Therapeutics Plc stock forecast ,stock prediction 2023 2024 2025

marketwatch ITRM – Iterum Therapeutics Plc yahoo finance google finance

stock history ITRM – Iterum Therapeutics Plc invest stock market

stock prices ITRM premarket after hours

ticker ITRM fair value insiders trading

AMRN – Amarin Corp ADR

AMRN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

2.94

Margin Of Safety %

-29

Put/Call OI Ratio

0.33

EPS Next Q Diff

0.19

EPS Last/This Y

1.79

EPS This/Next Y

0.99

Price

15.9

Target Price

12.5

Analyst Recom

Performance Q

8.45

Upside

-456.4%

Beta

0.77

Ticker: AMRN

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-06-02	AMRN	14.53	0.15	0.38	3114
2026-06-03	AMRN	14.54	0.15	0.10	3141
2026-06-04	AMRN	13.8	0.15	0.58	3143
2026-06-05	AMRN	13.93	0.16	0.16	3187
2026-06-08	AMRN	14.23	0.16	0.07	3205
2026-06-09	AMRN	14.9	0.16	0.70	3150
2026-06-10	AMRN	14.84	0.17	0.78	3243
2026-06-11	AMRN	14.95	0.17	0.00	3255
2026-06-12	AMRN	15.27	0.17	0.02	3257
2026-06-15	AMRN	15.32	0.17	0.00	3270
2026-06-16	AMRN	15.09	0.17	2.13	3277
2026-06-17	AMRN	15.91	0.18	0.47	3298
2026-06-18	AMRN	15.97	0.18	0.05	3280
2026-06-22	AMRN	15.93	0.15	0.29	1419
2026-06-23	AMRN	16.05	0.21	30.00	1994
2026-06-24	AMRN	16.46	0.28	0.03	2114
2026-06-25	AMRN	16.45	0.27	3.93	2228
2026-06-26	AMRN	15.95	0.33	0.00	2354
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-06-01	AMRN	14.44	-100.0	-	-0.01
2026-06-02	AMRN	14.55	-100.0	-	-0.01
2026-06-03	AMRN	14.50	-100.0	-	-0.01
2026-06-04	AMRN	13.83	-100.0	-	-0.01
2026-06-05	AMRN	13.92	-100.0	-	-0.01
2026-06-08	AMRN	14.20	-100.0	-	-0.01
2026-06-09	AMRN	14.89	-100.0	-	-0.01
2026-06-10	AMRN	14.83	-100.0	-	-0.01
2026-06-11	AMRN	14.95	-100.0	-	-0.01
2026-06-12	AMRN	15.32	-100.0	-	-0.01
2026-06-15	AMRN	15.35	-100.0	-	-0.01
2026-06-16	AMRN	15.09	-100.0	-	-0.01
2026-06-17	AMRN	15.77	-100.0	-	-0.01
2026-06-18	AMRN	15.98	-100.0	-	-0.01
2026-06-22	AMRN	15.83	-100.0	-	-0.01
2026-06-23	AMRN	16.03	-100.0	-	-0.01
2026-06-24	AMRN	16.36	-100.0	-	-0.01
2026-06-25	AMRN	16.36	-100.0	-	-0.01
2026-06-26	AMRN	15.90	-100.0	-	-0.01
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-06-02	AMRN	0.00	0.32	2.97
2026-06-03	AMRN	0.00	0.32	2.97
2026-06-04	AMRN	0.00	0.32	2.97
2026-06-05	AMRN	0.00	0.32	2.97
2026-06-08	AMRN	0.00	0.32	2.97
2026-06-09	AMRN	0.00	0.32	2.97
2026-06-10	AMRN	0.00	0.32	2.99
2026-06-11	AMRN	0.00	0.32	2.99
2026-06-12	AMRN	0.00	0.32	2.99
2026-06-15	AMRN	0.00	0.32	2.99
2026-06-16	AMRN	0.00	0.32	2.99
2026-06-17	AMRN	0.00	0.32	2.99
2026-06-18	AMRN	0.00	0.32	2.99
2026-06-22	AMRN	0.00	0.32	2.99
2026-06-23	AMRN	0.00	0.32	2.99
2026-06-24	AMRN	0.00	0.32	2.99
2026-06-25	AMRN	0.00	0.32	2.99
2026-06-26	AMRN	0.00	0.32	2.94
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

-0.2

Avg. EPS Est. Current Quarter

-0.1

Avg. EPS Est. Next Quarter

-0.01

Insider Transactions

Institutional Transactions

0.32

Beta

0.77

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

11.3

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

86.7

Max Drawdown 5-Year %

-93.1

Target Price

12.5

P/E

Forward P/E

289.27

PEG

P/S

1.54

P/B

0.74

P/Free Cash Flow

EPS

-1.62

Average EPS Est. Cur. Y

-0.01

EPS Next Y. (Est.)

0.98

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-15.52

Relative Volume

Return on Equity vs Sector %

-34.9

Return on Equity vs Industry %

-45.5

EPS 1 7Days Diff

-0.8

EPS 1 30Days Diff

-0.79

EBIT Estimation

◆ AMRN Healthcare

$15.91

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

2/25

Volume

4/15

Valuation

9/20

TP/AR

0/10

Options

7/10

RSI

60.4

Range 1M

67.7%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

2/25

Growth

23/30

Estimates

2/20

Inst/Vol

5/15

Options

8/10

EPS Yr

61.1%

EPS NY

257.1%

52W%

39.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +44.8% upside

Quality

5/30

Valuation

15/30

Growth

19/25

Stability

7/10

LT Trend

1/5

Upside

+44.8%

Quality

MoS

-29%

AMRN — P/E HistoricalBiotechnology

Amarin Corporation plc

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 80

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

AMRN

Latest News

—

Caricamento notizie per AMRN…

stock quote shares AMRN – Amarin Corp ADR Stock Price stock today

news today AMRN – Amarin Corp ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch AMRN – Amarin Corp ADR yahoo finance google finance

stock history AMRN – Amarin Corp ADR invest stock market

stock prices AMRN premarket after hours

ticker AMRN fair value insiders trading

ALKS – Alkermes plc

ALKS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

11.02

Margin Of Safety %

-40

Put/Call OI Ratio

0.72

EPS Next Q Diff

0.64

EPS Last/This Y

-0.49

EPS This/Next Y

0.57

Price

55.13

Target Price

48.12

Analyst Recom

1.44

Performance Q

84.09

Upside

-42.8%

Beta

0.3

Ticker: ALKS

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-06-02	ALKS	41.33	0.74	1.99	10403
2026-06-03	ALKS	42.76	0.74	0.80	10418
2026-06-04	ALKS	43.38	0.75	0.04	10484
2026-06-05	ALKS	42.79	0.74	0.06	10597
2026-06-08	ALKS	42.43	0.74	0.19	11154
2026-06-09	ALKS	44.29	0.73	0.03	11222
2026-06-10	ALKS	43.82	0.80	0.06	10738
2026-06-11	ALKS	44.96	0.81	0.09	10723
2026-06-12	ALKS	44.29	0.80	0.05	10753
2026-06-15	ALKS	44.34	0.80	0.06	10743
2026-06-16	ALKS	44.07	0.51	0.00	14343
2026-06-17	ALKS	44.49	0.46	0.11	15332
2026-06-18	ALKS	44.92	0.46	0.01	15324
2026-06-22	ALKS	46.06	0.50	0.98	12403
2026-06-23	ALKS	48.06	0.64	0.50	18430
2026-06-24	ALKS	50.45	0.64	0.81	19266
2026-06-25	ALKS	52.85	0.72	0.13	22677
2026-06-26	ALKS	55.08	0.72	1.54	22717
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-06-01	ALKS	42.26	-51.6	-	1.43
2026-06-02	ALKS	41.31	-51.6	-	1.43
2026-06-03	ALKS	42.76	-51.6	-	1.43
2026-06-04	ALKS	43.37	-51.6	-	1.43
2026-06-05	ALKS	42.79	-51.6	-	1.43
2026-06-08	ALKS	42.45	-51.6	-	1.43
2026-06-09	ALKS	44.29	-51.6	-	1.43
2026-06-10	ALKS	43.83	-51.6	-	1.43
2026-06-11	ALKS	44.97	-51.6	-	1.43
2026-06-12	ALKS	44.31	-51.6	-	1.43
2026-06-15	ALKS	44.37	-51.6	-	1.43
2026-06-16	ALKS	44.06	-51.6	-	1.43
2026-06-17	ALKS	44.49	-51.6	-	1.43
2026-06-18	ALKS	44.97	-51.6	-	1.43
2026-06-22	ALKS	46.04	-51.6	-	1.43
2026-06-23	ALKS	48.07	-72.7	-	0.98
2026-06-24	ALKS	50.44	-72.7	-	0.98
2026-06-25	ALKS	52.86	-72.7	-	0.98
2026-06-26	ALKS	55.13	-72.7	-	0.98
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-06-02	ALKS	-4.03	-1.51	11.22
2026-06-03	ALKS	-4.03	-1.51	11.22
2026-06-04	ALKS	-4.03	-1.51	11.22
2026-06-05	ALKS	-4.08	-1.51	11.22
2026-06-08	ALKS	-4.01	-1.48	11.22
2026-06-09	ALKS	-4.01	-1.48	11.22
2026-06-10	ALKS	-4.01	-1.48	10.65
2026-06-11	ALKS	-4.01	-1.48	10.65
2026-06-12	ALKS	-4.01	-1.48	10.65
2026-06-15	ALKS	-4.06	-1.44	10.65
2026-06-16	ALKS	-4.06	-1.44	10.65
2026-06-17	ALKS	-4.06	-1.44	10.65
2026-06-18	ALKS	-4.06	-1.44	10.65
2026-06-22	ALKS	-4.06	-1.48	10.65
2026-06-23	ALKS	-4.01	-1.48	10.65
2026-06-24	ALKS	-4.01	-1.48	10.65
2026-06-25	ALKS	-4.01	-1.48	10.65
2026-06-26	ALKS	-4.01	-1.48	11.02
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

-0.4

Avg. EPS Est. Current Quarter

0.19

Avg. EPS Est. Next Quarter

0.24

Insider Transactions

-4.01

Institutional Transactions

-1.48

Beta

0.3

Average Sales Estimate Current Quarter

457

Average Sales Estimate Next Quarter

472

Fair Value

33.16

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

-2.7

Max Drawdown 5-Year %

-33.2

Target Price

48.12

P/E

61.23

Forward P/E

98.02

PEG

P/S

5.88

P/B

5.23

P/Free Cash Flow

41.39

EPS

0.9

Average EPS Est. Cur. Y

0.98

EPS Next Y. (Est.)

1.56

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

9.78

Relative Volume

3.1

Return on Equity vs Sector %

-18.7

Return on Equity vs Industry %

1.8

EPS 1 7Days Diff

-0.4

EPS 1 30Days Diff

-0.45

EBIT Estimation

◆ ALKS Healthcare

$55.08

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

4/25

Volume

3/15

Valuation

5/20

TP/AR

2/10

Options

4/10

RSI

87.7

Range 1M

92.9%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

WEAK

Momentum

24/25

Growth

16/30

Estimates

4/20

Inst/Vol

7/15

Options

3/10

EPS Yr

-127.8%

EPS NY

241.2%

52W%

95.8%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🔴 SELL -14.9% upside

Quality

8/30

Valuation

1/30

Growth

11/25

Stability

5/10

LT Trend

4/5

Upside

-14.9%

Quality

MoS

-40%

ALKS — P/E HistoricalBiotechnology

Alkermes plc

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 2050

Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

ALKS

Latest News

—

Caricamento notizie per ALKS…

stock quote shares ALKS – Alkermes plc Stock Price stock today

news today ALKS – Alkermes plc stock forecast ,stock prediction 2023 2024 2025

marketwatch ALKS – Alkermes plc yahoo finance google finance

stock history ALKS – Alkermes plc invest stock market

stock prices ALKS premarket after hours

ticker ALKS fair value insiders trading

No more stocks to show

SW – Smurfit WestRock plc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SW

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

MURA – Mural Oncology plc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: MURA

No data found

No data found

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y